Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Slp5 Inhibitors

SLP-5 Inhibitors belong to a class of chemical compounds designed to selectively modulate the activity of the SH2 domain-containing leukocyte protein of 76 kDa (SLP-5), also known as BASH (SLP-76-associated protein). SLP-5 is recognized for its role in immune cell signaling, particularly in T-cell receptor activation and downstream cellular responses. These inhibitors are strategically designed to target the interactions and pathways involving SLP-5, aiming to influence immune cell functions. The chemical structures of SLP-5 inhibitors often exhibit specific features intended to disrupt the binding interfaces or enzymatic activities associated with SLP-5, consequently affecting its downstream signaling cascades.

These inhibitors can function by interacting with critical regions of SLP-5, such as its protein-protein interaction domains or enzymatic pockets, ultimately hindering its interactions with other signaling molecules and interfering with its normal cellular functions. Some SLP-5 inhibitors may exhibit similar structural motifs as natural ligands that bind to SLP-5, aiming to outcompete these ligands and disrupt their binding to the protein. Others may adopt distinct chemical scaffolds to target unique sites on SLP-5, thus inhibiting its activation or inhibiting its participation in intricate immune signaling networks. The development of SLP-5 inhibitors requires a deep understanding of the protein's structure, interactions, and associated pathways. These inhibitors serve as indispensable tools in deciphering the precise roles of SLP-5 in immune responses and the broader implications of its modulation in cellular processes. By offering researchers the means to manipulate SLP-5's activity in a controlled manner, this class of compounds contributes to the exploration of fundamental immunological mechanisms and aids in unraveling the intricate web of molecular events governing immune cell activation and subsequent responses.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib targets several Src family kinases, which are linked to T-cell receptor signaling and immune responses.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

A compound that inhibits Src family kinases, including Lck and Fyn, which are key players in T-cell receptor signaling pathways involving SLP-5.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib has some inhibitory effects on Src family kinases implicated in immune cell activation and SLP-5 signaling.

SU6656

330161-87-0sc-203286
sc-203286A
1 mg
5 mg
$57.00
$133.00
27
(1)

A selective inhibitor of Src family kinases, SU6656 has been used in research to explore the roles of these kinases in immune cell signaling, which could indirectly impact SLP-5 activity.

PP 1

172889-26-8sc-203212
sc-203212A
1 mg
5 mg
$86.00
$145.00
6
(1)

Similar to PP2, PP1 is a compound that inhibits Src family kinases and has been utilized in studies involving T-cell receptor signaling pathways.

Saracatinib

379231-04-6sc-364607
sc-364607A
10 mg
200 mg
$115.00
$1056.00
7
(1)

An inhibitor of multiple Src family kinases, saracatinib's effects on immune cell signaling may indirectly affect SLP-5-mediated processes.

BAY 61-3606

sc-507485
2 mg
$345.00
1
(0)

Known to inhibit Syk kinase, which plays a role in immune cell activation, BAY 61-3606 could potentially influence SLP-5-associated pathways.